◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › MCK

McKesson Corporation (MCK) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Distributors · DATA UPDATED 2026-07-13

McKesson Corporation (MCK) operates in the Health Care Distributors industry and is headquartered in Irving, United States with about 41,600 employees. Its market capitalization is roughly $98 billion. In the fiscal year ended 2026-03-31, MCK reported $403.4B in revenue and $4.8B in net income.

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.

Interactive charts & full statements → Open the MCK valuation workbench →

MCK Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-03-312026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-31
Total Revenue$403.4B$403.4B$359.1B$309.0B$276.7B$264.0B$238.2B$231.1B$214.3B$208.4B$198.5B$190.9B$179.0B$137.6B$122.5B$122.7B$112.1B$108.7B$106.6B$101.7B$93.0B
Gross Profit$14.6B$14.6B$12.5B$12.2B$11.9B$12.6B$11.6B$11.4B$10.8B$10.4B$10.7B$10.9B$10.9B$8.0B$6.8B$6.4B$6.0B$5.7B$5.4B$5.0B$4.3B
Gross Margin %3.6%3.6%3.5%4.0%4.3%4.8%4.9%4.9%5.0%5.0%5.4%5.7%6.1%5.8%5.5%5.2%5.3%5.2%5.1%4.9%4.7%
Operating Income (EBIT)$6.4B$6.5B$4.4B$3.9B$4.5B$2.7B$3.5B$3.0B$3.1B$2.9B$3.4B$3.9B$3.5B$2.6B$2.4B$2.4B$2.1B$2.0B$1.7B$1.5B$1.3B
Operating Margin %1.6%1.6%1.2%1.3%1.6%1.0%1.5%1.3%1.4%1.4%1.7%2.0%2.0%1.9%2.0%1.9%1.9%1.8%1.6%1.5%1.4%
Net Income$4.8B$4.8B$3.3B$3.0B$3.6B$1.1B($4.5B)$900M$34M$67M$5.2B$2.3B$1.5B$1.3B$1.3B$1.4B$1.1B$1.3B$823M$990M$963M
Net Margin %1.2%1.2%0.9%1.0%1.3%0.4%-1.9%0.4%0.0%0.0%2.6%1.2%0.8%0.9%1.1%1.1%1.0%1.2%0.8%1.0%1.0%
EBITDA$7.0B$7.2B$5.3B$4.7B$5.7B$3.1B($3.6B)$2.3B$1.8B$1.5B$8.1B$4.5B$4.0B$3.1B$2.7B$2.7B$2.3B$2.5B$1.6B$2.0B$1.7B
Earnings Per Share (EPS)$38.47$38.37$25.72$22.39$25.04$7.23$-28.26$4.95$0.17$0.32$23.24$9.69$6.28$5.42$5.60$5.59$4.30$4.63$2.95$3.32$3.16
Shares Outstanding (M)123M124M128M134M142M154M161M182M197M209M223M233M235M233M239M251M263M273M279M298M305M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MCK Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue$96.3B$106.2B$103.2B$97.8B$90.8B$95.3B$93.7B$79.3B
Gross Profit$4.0B$3.7B$3.5B$3.3B$2.9B$3.2B$3.1B$3.0B
Gross Margin %4.2%3.5%3.4%3.4%3.2%3.4%3.4%3.7%
Operating Income (EBIT)$2.2B$1.6B$1.5B$1.0B$1.0B$1.3B$745M$1.1B
Operating Margin %2.3%1.5%1.4%1.1%1.1%1.4%0.8%1.3%
Net Income$1.7B$1.2B$1.1B$784M$1.3B$879M$241M$915M
Net Margin %1.8%1.1%1.1%0.8%1.4%0.9%0.3%1.1%
EBITDA$2.3B$1.8B$1.7B$1.3B$1.7B$1.4B$775M$1.3B
Earnings Per Share (EPS)$13.71$9.59$8.92$6.25$10.01$6.94$1.86$7.00
Shares Outstanding (M)123M124M124M126M126M127M129M131M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MCK Free Cash Flow History

Cash flowTTM → 2026-03-312026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-31
Cash from Operations (CFO)$6.2B$6.2B$6.1B$4.3B$5.2B$4.4B$4.5B$4.4B$4.0B$4.3B$4.7B$3.7B$3.1B$3.1B$2.5B$3.0B$2.3B$2.3B$1.4B$869M$1.5B
Capital Expenditures (CapEx)$441M$436M$859M$687M$558M$535M$641M$506M$557M$580M$562M$677M$545M$415M$406M$403M$388M$378M$392M$356M$306M
Free Cash Flow (FCF)$5.7B$5.7B$5.2B$3.6B$4.6B$3.9B$3.9B$3.9B$3.5B$3.8B$4.2B$3.0B$2.6B$2.7B$2.1B$2.5B$1.9B$1.9B$959M$513M$1.2B
FCF Margin %1.4%1.4%1.5%1.2%1.7%1.5%1.6%1.7%1.6%1.8%2.1%1.6%1.4%2.0%1.7%2.1%1.7%1.8%0.9%0.5%1.3%
Dividends Paid$381M$381M$345M$314M$292M$277M$276M$294M$292M$262M$253M$244M$227M$214M$194M$195M$171M$131M$116M$70M$72M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MCK Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Cash from Operations (CFO)$3.4B$1.2B$2.4B($918M)$7.7B($2.4B)$2.1B($1.4B)
Capital Expenditures (CapEx)$111M$108M$111M$111M$278M$196M$218M$167M
Free Cash Flow (FCF)$3.3B$1.1B$2.3B($1.0B)$7.5B($2.6B)$1.9B($1.5B)
FCF Margin %3.4%1.1%2.2%-1.1%8.2%-2.7%2.0%-1.9%
Dividends Paid$101M$101M$89M$90M$91M$92M$80M$82M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MCK Balance Sheet History

Balance sheet2026-03-312026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-31
Total Assets$82.3B$82.3B$75.1B$67.4B$62.3B$63.3B$65.0B$61.2B$59.7B$60.4B$61.0B$56.6B$53.9B$51.8B$34.8B$33.1B$30.9B$28.2B$25.3B$24.6B$23.9B
Cash & Cash Equivalents$4.0B$4.0B$5.7B$4.6B$4.7B$3.5B$6.3B$4.0B$3.0B$2.7B$2.8B$4.0B$5.3B$4.2B$2.5B$3.1B$3.6B$3.7B$2.1B$1.4B$2.0B
Total Liabilities$83.2B$83.2B$76.8B$69.0B$63.8B$65.1B$63.6B$54.5B$50.0B$48.9B$48.4B$46.1B$44.4B$41.4B$27.7B$26.3B$23.7B$20.7B$19.1B$18.5B$17.7B
Total Debt (Short + Long-Term)$6.8B$6.8B$5.9B$5.9B$5.9B$6.2B$7.5B$7.7B$7.6B$4.7B$5.6B$4.3B$9.8B$10.4B$4.9B$4.0B$4.0B$2.3B$2.5B$1.8B$2.0B
Total Shareholders' Equity($2.2B)($2.2B)($1.7B)($1.6B)($1.5B)($1.8B)$1.4B$6.7B$9.7B$11.5B$12.6B$10.4B$9.5B$10.3B$7.1B$6.8B$7.2B$7.5B$6.2B$6.1B$6.3B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MCK viewer.

Other Companies in Health Care Distributors

← MCIAll stocksMCN →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.